[11C] (+)-4-propyl-(+)-4-propyl-9-hydroxynaphthoxazine (PHNO)

DRUG2 trials

Sponsors

Neurocrine Biosciences, Medical University of Vienna

Conditions

First Episode Psychosis (FEP)Healthy Volunteers

Phase 1

A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)

CompletedNCT02959892

Neurocrine BiosciencesHealthy Volunteers

Start: 2016-12-05End: 2017-08-23Updated: 2021-03-19

Unknown Phase

Dopamine and Insulin in Psychosis

Not yet recruitingNCT07252752

Medical University of ViennaFirst Episode Psychosis (FEP)

Start: 2026-01-01End: 2029-01-01Target: 46Updated: 2025-11-28